Depresión y cánceruna revisión orientada a la práctica clínica

  1. Verónica Pousa Rodríguez 1
  2. Ana Miguelez Amboage 1
  3. Manuel Hernández Blázquez 1
  4. Miguel Ángel González Torres 1
  5. Moisés Gaviria 2
  1. 1 Hospital Universitario de Basurto
    info

    Hospital Universitario de Basurto

    Bilbao, España

    ROR https://ror.org/00j4pze04

  2. 2 University of Illinois Department of Psychiatry
Aldizkaria:
Revista Colombiana de Cancerología

ISSN: 2346-0199 0123-9015

Argitalpen urtea: 2015

Alea: 19

Zenbakia: 3

Orrialdeak: 166-172

Mota: Artikulua

DOI: 10.1016/J.RCCAN.2015.04.005 DIALNET GOOGLE SCHOLAR lock_openSarbide irekia editor

Beste argitalpen batzuk: Revista Colombiana de Cancerología

Objetivos de desarrollo sostenible

Laburpena

Depression is an entity that concerns about the15-25% of the patients with cancer. In spite of his high incident, it is habitually an under diagnosed disorder and do not receive adequate treatment. This fact drives to a worse quality of life, a worse adherence to the treatment and a minor rate of survival. There is evidence of the efficiency of pharmacological and psychological boardings in the patients with cancer and depression. The aim of this paper is to have a vision on those interventions with demonstrated efficiency. This treatment allows to the patients with cancer to develop a better confrontation of his disease and to achieve a better quality of life.

Erreferentzia bibliografikoak

  • Hernández, M,Cruzado, JA,Prado, C,Rodríguez, E,Hernández, C,González, MA. (2012). Salud mental y malestar emocional en pacientes con cáncer. Psicooncología. 9. 233
  • Hernádez, M,Cruzado, JA,Arana, Z. (2007). Problemas psicológicos en pacientes con cáncer: dificultades de detección y derivación al psicooncólogo. Psicooncología. 179
  • United States Center for Disease Control and Prevention. Cancer Incidence and Mortality Data.
  • Gil Moncayo, FL,Costa Requena, G,Javier Pérez, F,Salamero, M,Sánchez, N,Sirgo, A. (2008). Adaptación psicológica y prevalencia de trastornos mentales en pacientes con cáncer. Medicina clínica. 130. 90
  • Kadan-Lottick, NS,Vanderwerker, LC,Block, SD,Zhang, B,Prigerson, HG. (2005). Psyquiatric Disorders and mental health service use in patients with advanced cancer- A report from the coping with cancer study. Cancer. 104. 2872
  • Litofsky, NS,Farace, E,Anderson, F,Meyers, CA,Huang, W,Laws, ER. Depression in patients with high-grade glioma: results of the glioma outcomes project. Neurosurgery. 2004. 358
  • Arnold, SD,Forman, LM,Brigidi, BD,Carter, KE,Schweitzer, HA,Quinn, HE. (2008). Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors. Neuro Oncol. 10. 171
  • Fras, I,Litin, EM,Pearson, JS. (1967). Comparison of psychiatricsymptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasm. Am J Psychiatry. 123. 1553
  • Hopwood, P,Stephens, RJ. (2000). Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 18. 893-903
  • Kissane, DW,Grabsch, B,Love, A,Clarke, DM,Bloch, S,Smith, GC. (2004). Psychiatric disorder in woman with early stage and advanced breast cancer: a comparative analysis. Aust N Z J Psychiatry. 143. 447
  • Evans, DL,McCartney, CF,Nemeroff, CB,Raft, D,Quade, D,Golden, RN. (1986). Depression in woman treated for gynecological cancer: clinical and neuroendocrine assessment. Am J Psychiatry. 143. 447
  • Haeffel, DJ,Getchell, M,Koposov, RA,Yrigollen, CM,Deyoung, CG,Klinteberg, BA. (2008). Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol Sci. 19. 62
  • Sheline, YI,Gado, MH,Kraemer, HC. (2003). Untreated depression and hippocampal volume loss. Am J Psychiatry. 160. 1516
  • Drevets, WC,Savitz, J,Trimble, M. (2008). The subgenual anterior cingu-lated cortex in mood disorders. CNSSpectr. 13. 663
  • Sen, S,Duman, R,Sanacora, G. (2008). Serum BDNF, depression and anti-depressant medications: meta-analyses and implications. Biol Psychiatry. 64. 527
  • Kent, S,Bluthe, RM,Kelley, KW,Dantzer, R. (1992). Sickness behaviour as a new target for drug development. Trends Pharmacol Sci. 13. 24
  • Plotkin, SR,Banks, WA,Kastin, AJ. (1996). Comparison of saturable transport and extracellular pathways in the passage of interleukin-1 alpha across the blood-brain barrier. J Neuroim-munol. 67. 41
  • Rivest, S,Lacroix, S,Vallieres, L,Nadeau, S,Zhang, J,Laflamme, N. (2000). How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med. 223. 22-38
  • Berard, RM,Boermeester, F,Viljoen, G. (1998). Depressive disorders in a out-patient oncology setting: prevalence assessment and management. Psychooncology. 7. 112
  • Kissane, DW,Maj, M,Sartorius, N. (2011). Depression and cancer. John Wiley & Sons.
  • Papanicolaou, DA. (2000). Euthyroid sick syndrome and the role of cytokines. Rev Endocrinol Metab Dis. 1. 43
  • Pelletier, G,Verhoef, MJ,Khatrei, N,Hagan, N. (2002). Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 57. 41
  • Musselman, DL,Lawson, DD,Gumnick, JF,Manatunga, AK,Penna, S,Goodkin, RS. (2001). Paroxetine for the prevention of depression induced by high-dose interferon alpha. N Engl J Med. 344. 961
  • DiMatteo, MR,Lepper, HS,Croghan, TW. (2000). Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Int Med. 160. 2102
  • Jr, Loberiza FR,Rizzo, JD,Bredeson, CN,Antin, JH,Horowitz, MM,Weeks, JC. (2002). Association of depressive syndrome and early deaths among patients after stem-cel transplantation for malignant diseases. J Clin Oncol. 20. 2118
  • Yirmiya, R,Weidenfeld, J,Pollak, Y,Morag, M,Morag, A,Avitsur, R. (1999). Cytokines, ''depression due to a general medical condition'', and antidepressant drugs. Adv Exp Med Biol. 461. 283-316
  • Pelletier, G,Verhoef, MJ,Khatri, N,Hagen, N. (2002). Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neuroon-col. 57. 41
  • Lloyd-Williams, M,Shiels, C,Taylor, F,Dennis, M. (2009). Depression --- An independent predictor of early death in patients with advanced cancer. J Affect Disord. 113. 127
  • Passik, SD,Dugan, W,McDonald, MV,Rosenfeld, B,Theobald, DE,Edgerton, S. (1998). Oncologists' recognition of depression in their patients with cancer. J Clin Oncol. 1594-60016
  • Sôllner, W,DeVries, A,Steixner, E,Lukas PSprinzl, G,Rumpold, G. (2001). How successful are oncologists in identifying patient distress, percieved social support, and need for psychosocial counselling?. Br J Cancer. 84. 179
  • Fallowfield, L,Ratcliffe, D,Jenkins, V,Saul, J. (2001). Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer. 84. 1011
  • Weinberger, MI,Roth, AJ,Nelson, CJ. (2009). Untangling the complexities of depression diagnosis in older cancer patients. Oncologist. 14. 60
  • Vodermaier, A,Linden, W,Siu, C. (2009). Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst. 101. 1464
  • Hernández Blázquez, M. Estudio longitudinal del malestar emocional y los trastornos psicopatológicos en pacientes de cáncer que reciben tratamiento de radioterapia.
  • Miguel, C,Albuquerque, E. (2011). Drug Interaction in Psychooncology: antidepressants and antineoplastics. Pharmacology. 88. 333
  • Stahl, B,Goldstein, E. (2011). Mindfulness para reducir el estrés: una guía práctica. Editorial Kairós. Barcelona.
  • Rodríguez Vega, B,Bayón Pérez, C. (2013). Comunicación personal: Integrando mindfulness y psicoterapia. Fundación OMIEServicio de Psiquiatría del Hospital de Basurto. Bilbao.
  • Hofmann, S,Sawyer, A,Witt, A,Oh, D. (2010). The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review. J consult clin psychol. 78. 169
  • Redondo, R. (2008). Zen, la experiencia del asombro. Fabrikart: arte, tecnología industria, sociedad. 8. 212
  • Shennan, C,Payne, S,Fenlon, D. (2011). What is the evidence for the use for mindfulness-based interventions in cancer care?. Psychooncology. 20. 681
  • Rodríguez, B,Priede, A,Maeso, A,Arranz, H,Palao, A. (2011). Cambios psicológicos e intervenciones basadas en mindfulness para los supervivientes de un cáncer. Psicooncología. 8. 7-20
  • Watson, M,Kissane, DW. (2011). Handbook of psychotherapy in cancer care. Wiley-Blackwell. Chichester^eUKWest Sussex UK.
  • Birnie, K,Garland, S,Carlson, L. (2010). Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR). Psychooncology. 19. 1004
  • Valiente, M. (2006). El uso de la visualización en el tratamiento psicológico de enfermos de cáncer. Psicooncología. 3. 19-34
  • Walker, LG,Anderson, J. (1999). Testing complementary and alternative medicine within a research protocol. Eur J Cancer. 35. 1614
  • Cheung, YL,Molasiotiss, A,Chang, AM. (2003). The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psychooncology. 12. 254
  • Dimeo, FC,Thomas FRabe-Menssen, C,Prõpper FMathias, M. (2004). Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomized controlled trial. Supportive Care Cancer. 12. 774
  • Baider, L,Peretz, T,Hadani, PE,Koch, U. (2001). Psychological intervention in cancer patients: a randomized study. Gen Hosp Psychiatry. 23. 272
  • Luebbert, K,Dahme, B,Hasenbring, M. (2001). The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: a meta-analytical review. Psychooncology. 10. 490-502
  • Miller, J,Hopkinson, C. (2008). A retrospective audit exploring the use of relaxation as an intervention in oncology and palliative care. Eur J Cancer Care. 17. 488